OIM
PFE icon

Oracle Investment Management’s Pfizer PFE Stock Holding History

Oracle Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-550,000
Closed -$1.26M – 37
2022
Q1 		$1.26M Sell
550,000
-850,000
-61% -$44.1M 0.25% 21
2021
Q4 		$15M Buy
+1,400,000
New +$69.4M 2.14% 10

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Oracle Investment Management's PFE Position: Q1 2022 in Review

Oracle Investment Management sold out of Pfizer (PFE) in Q1 2022, closing a stake of 475,000 shares — an estimated $24.6M sold.

Oracle Investment Management first reported a position in PFE in Q4 2021 and held it in 1 quarter. The position peaked at $28M in Q4 2021. 3,196 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • Oracle Investment Management reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
  • Oracle Investment Management sold 475,000 Pfizer shares in Q1 2022, an estimated $24.6M.
  • Oracle Investment Management first reported a position in Pfizer in Q4 2021 and held it in 1 quarter.
  • Oracle Investment Management's Pfizer position peaked at $28M in Q4 2021.
  • 3,196 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Oracle Investment Management's 13F filing for Q1 2022, filed 16 May 2022.